What is the recommended dosage of Unasyn (Ampicillin/Sulbactam) for treating infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Unasyn (Ampicillin-Sulbactam) Dosing

The standard adult dose of Unasyn is 1.5 to 3 grams IV every 6 hours, with the total sulbactam component not exceeding 4 grams per day. 1

Standard Adult Dosing

  • 1.5 grams (1g ampicillin/0.5g sulbactam) to 3 grams (2g ampicillin/1g sulbactam) IV every 6 hours is the FDA-approved dosing range 1
  • Administer by slow IV injection over 10-15 minutes, or as an infusion in 50-100 mL compatible diluent over 15-30 minutes 1
  • The maximum total sulbactam dose should not exceed 4 grams daily 1
  • IM administration is also approved, given by deep intramuscular injection 1

Pediatric Dosing (≥1 Year of Age)

  • 300 mg/kg/day IV (total ampicillin + sulbactam content) divided every 6 hours is the standard pediatric dose 1
  • This corresponds to 200 mg/kg/day ampicillin plus 100 mg/kg/day sulbactam 1
  • Children weighing ≥40 kg should receive adult dosing 1
  • Maximum sulbactam dose should not exceed 4 grams per day 1
  • IM administration safety and efficacy have not been established in pediatric patients 1
  • Treatment duration should not routinely exceed 14 days IV 1

High-Dose Regimens for Severe/Resistant Infections

For severe infections or multidrug-resistant organisms (particularly Acinetobacter baumannii), higher doses of 9-12 grams sulbactam per day are recommended. 2, 3

  • 9-12 g/day sulbactam divided into 3-4 doses for severe infections caused by organisms with MIC ≤4 mg/L 2, 3
  • Administer as 4-hour extended infusions to optimize pharmacokinetic/pharmacodynamic properties 2, 3
  • This translates to approximately 3-4 grams sulbactam every 8 hours 3

Clinical Context for High-Dose Therapy

  • High-dose sulbactam is particularly effective for carbapenem-resistant Acinetobacter baumannii (CRAB) infections 2, 3
  • Clinical outcomes with high-dose sulbactam for severe A. baumannii infections are comparable to imipenem 2
  • Sulbactam demonstrates lower nephrotoxicity rates compared to colistin, making it preferable for susceptible strains 2, 3

Specific Infection Dosing

Endocarditis (Adults)

  • 12 g/day IV in 4 equally divided doses (3g every 6 hours) combined with gentamicin 3 mg/kg/day for 4-6 weeks 4
  • For HACEK endocarditis: 12 g/24 hours IV in 4 divided doses for 4 weeks (native valve) or 6 weeks (prosthetic valve) 4

Endocarditis (Pediatric)

  • 300 mg/kg/day IV in 4-6 equally divided doses for 4-6 weeks 4

Complicated Intra-Abdominal Infections (Pediatric)

  • 200 mg/kg/day IV divided every 6 hours 4

Surgical Site Infections

  • 3 grams every 6 hours IV when used in combination with gentamicin or tobramycin 5 mg/kg every 24 hours for infections involving intestinal or genitourinary tract 2

Renal Impairment Dosing

Dosing frequency must be reduced in renal impairment while maintaining the same individual dose range (1.5-3 grams). 1

  • CrCl ≥30 mL/min: 1.5-3 grams every 6-8 hours 1
  • CrCl 15-29 mL/min: 1.5-3 grams every 12 hours 1
  • CrCl 5-14 mL/min: 1.5-3 grams every 24 hours 1

The elimination kinetics of ampicillin and sulbactam are similarly affected by renal impairment, maintaining a constant ratio 1

Common Pitfalls to Avoid

  • Underdosing for resistant organisms: Standard doses (≤6 g/day sulbactam) may be insufficient for severe infections caused by multidrug-resistant pathogens 3
  • Not using extended infusions for high-dose therapy: 4-hour infusions are critical for optimizing efficacy and safety when using 9-12 g/day sulbactam 2, 3
  • Exceeding maximum sulbactam dose: Never exceed 4 grams sulbactam per day in standard dosing (this limit does not apply to high-dose regimens for resistant organisms) 1
  • Ignoring local resistance patterns: Sulbactam efficacy depends on MIC values; verify susceptibility testing shows MIC ≤4 mg/L before selecting sulbactam-based therapy 2, 3
  • Using IM route in pediatrics without established safety data: Stick to IV administration in children 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

High-Dose Sulbactam Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Unasyn Dosing Guidelines for Specific Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.